Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
82 studies found for:    Open Studies | "Cholangiocarcinoma"
Show Display Options
Rank Status Study
1 Recruiting Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Morphological Diagnosis of Hilar Cholangiocarcinoma (Excluded Type 1), Resectable With Expected R0 Margins on an intent-to Treat Basis.
Interventions: Procedure: CAPECITABINE-Radiotherapy -Liver Transplantation;   Procedure: RESECTION
2 Recruiting A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Conditions: Unresectable Intrahepatic Cholangiocarcinoma;   Resectable Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Surgery;   Radiation: Radiation
3 Recruiting Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma
Conditions: Intrahepatic Cholangiocarcinoma;   Peripheral Cholangiocarcinoma;   Cholangiolar Carcinoma;   Cholangiocellular Carcinoma) (ICC)
Interventions: Procedure: Liver resection and placement of hepatic artery infusion pump;   Drug: FLOXURIDINE;   Drug: DEXAMETHASONE;   Drug: GEMCITABINE
4 Recruiting Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
Conditions: Intrahepatic Cholangiocarcinoma;   Peripheral Cholangiocarcinoma;   Cholangiolar Carcinoma;   Cholangiocellular Carcinoma
Interventions: Drug: Floxuridine (FUDR);   Drug: dexamethasone;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Other: MRI;   Other: Research blood draws
5 Recruiting International Registry on Cholangiocarcinoma Treatment
Condition: Cholangiocarcinoma
Intervention: Drug: Doxorubicin
6 Recruiting Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Nab-Paclitaxel and Gemcitabine
7 Unknown  Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Condition: Cholangiocarcinoma
Intervention: Drug: RAD001
8 Recruiting Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine, Oxaliplatin, Capecitabine,;   Drug: Panitumumab, Gemcitabine, Oxaliplatin, Capecitabine
9 Unknown  Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Drainage;   Surgery
Intervention: Procedure: Preoperative biliary drainage
10 Recruiting Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Biliary Stricture;   Biliary Obstruction;   Bile Duct Cancer
Intervention: Procedure: Photodynamic Therapy
11 Recruiting Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: CX-4945;   Drug: Cisplatin;   Drug: Gemcitabine
12 Recruiting Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Procedure: Self expanding metallic stent (SEMS);   Procedure: Endoscopic radiofrequency ablation (ERFA);   Procedure: Photodynamic therapy (PDT)
13 Recruiting Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Capecitabine;   Drug: Panitumumab;   Drug: Bevacizumab
14 Recruiting Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
Condition: Hilar Cholangiocarcinoma
Interventions: Drug: Photodynamic therapy-Photofrin;   Procedure: Stenting procedure;   Drug: Chemotherapy regimen Gemcitabine/Cisplatin
15 Recruiting Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Condition: Cholangiocarcinoma
Intervention: Other: Observation data collection study.
16 Not yet recruiting Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
Condition: Hilar Cholangiocarcinoma
Interventions: Procedure: bilateral metal stent insertion;   Procedure: unilateral metal stent insertion
17 Recruiting Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Radiation: Therasphere® in association with Gemcitabine and Cisplatin
18 Recruiting Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Other: exposure to different risk factors and molecular assessment
19 Recruiting A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Condition: Cholangiocarcinoma
Interventions: Drug: Amphinex and Gemcitabine;   Drug: Gemcitabine and Cisplatin
20 Recruiting Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Conditions: Unresectable Cholangiocarcinoma;   Biliary Obstruction;   Stent Obstruction;   Biliary Stricture
Intervention: Procedure: Photodynamic Therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years